Development of Endocyclic Control Elements for Peptide Macrocycles
- 19 June 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 140 (28) , 8763-8770
Abstract
Synthetic methods that provide control over macrocycle conformation represent valuable tools for the discovery of bioactive molecules. Incorporation of heterocycles into cyclic peptides may offer a way to stabilize their solution conformations. Herein, we used N-(isocyanimino)triphenylphosphorane (Pinc) to install an oxadiazole ring and an endocyclic amine into peptide macrocycles. To elucidate the conformational effect of this constellation of functionalities, we performed synthesis, variable temperature NMR analysis, and NOE-based molecular dynamics simulation of a range of macrocycles in DMSO. As part of this study, we conducted experiments to compare macrocycle conformation in aqueous and DMSO solutions. The obtained solution structures suggest that the reduced amide bond/heterocycle (RAH) motif can stabilize macrocycle conformations in both water and DMSO, which addresses an enduring challenge in molecular design. The conformational effect of the RAH was used in an effort to mimic the biologically relevant secondary structure of MAdCAM-1. This resulted in the discovery of a novel α4β7 integrin antagonist.Keywords
Funding Information
- Canadian Institutes of Health Research
- Japan Society for the Promotion of Science
- Natural Sciences and Engineering Research Council of Canada
This publication has 52 references indexed in Scilit:
- Discovery and optimization of peptide macrocyclesExpert Opinion on Drug Discovery, 2016
- Macrocycles: lessons from the distant past, recent developments, and future directionsChemical Science, 2014
- Constraining Cyclic Peptides To Mimic Protein Structure MotifsAngewandte Chemie International Edition, 2014
- Comprehensive analysis of loops at protein-protein interfaces for macrocycle designNature Chemical Biology, 2014
- The Future of Peptide‐based DrugsChemical Biology & Drug Design, 2012
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical EvaluationAnti-Cancer Agents in Medicinal Chemistry, 2010
- Template-Constrained Somatostatin Analogues: A Biphenyl Linker Induces a Type-V‘ TurnJournal of the American Chemical Society, 2001
- Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer TherapyAngewandte Chemie International Edition, 1997
- Three-dimensional structure of echistatin, the smallest active RGD proteinBiochemistry, 1991
- Turns in Peptides and Proteins1985